COVID-19 (SARS-CoV-2 infection) (clinical diagnosis or confirmed laboratory diagnosis) and obesity (BMI >30 kg/m²) Infections and Infestations
Conditions
Interventions
This study includes COVID-19 positive patients who required hospitalisation in the emergency room (EM), regular hospitalization or hospitalization in the intensive care unit (ICU).
Giv
Sponsors
Novo Nordisk Pharma S.A.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients admitted to the HCSC in hospitalization regimen (primary care health care not included) between 01/03/2020-30/06/2020 with main and/or secondary diagnosis (ICD-10 codes): U07.1, U07.2, B34.2, B97.2, J12.81, J12.89, J12.90, J18.8, J18.9 or B97.29 + [J12.89, J12, J22, J40, J80, J98.8] and registered in the BDCLIN_HCSC_COVID-19 database 2. Patients with COVID-19 microbiological diagnosis (positive PCR) and registered in the BDCLIN_HCSC_COVID-19 database from 01/03/2020 to 30/06/2020
Exclusion criteria
Exclusion criteria: Does not meet inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients with obesity (BMI =30 kg/m²) obtained from medical records of COVID-19 positive patients hospitalized in HCSC in Madrid (Spain) from 01/03/2020 to 30/06/2020 | — |
Secondary
| Measure | Time frame |
|---|---|
| Obtained from medical records of COVID-19 positive patients hospitalized in HCSC in Madrid (Spain) from 01/03/2020 to 30/06/2020: 1. Percentage of patients with obesity (BMI =30 kg/m²) and at least one obesity-associated comorbidity (DM, HTA, and CVD*) *Cardiovascular diseases (CVD): coronary heart disease, stroke, hypertensive heart disease, inflammatory heart disease, rheumatic heart disease, TIA, and other cardiovascular diseases such as tumours, cardiomyopathy, and heart valve diseases 2. Percentage of patients with obesity (BMI =30 kg/m²), or obesity and at least one of the associated comorbidities (DM, HT, and CVD) per type of hospitalization: emergency room (EM), regular hospitalization or hospitalization at intensive care unit (ICU) 3. Percentage of patients in each group (BMI =30 kg/m² and BMI <30 kg/m²) by patient outcome: need for hospitalization, need for invasive ventilation, need for ICU admission, and mortality. 4. Percentage of obesity (BMI =30 kg/m²) and percentage of associated comorbidities (DM, HT and CVD) per different patient outcome. Obesity will be stratified in three different grades: grade 1: BMI =30-34.9 kg/m²; grade 2: BMI =35-39.9 kg/m² and grade 3: BMI =40 kg/m² 5. Mean cost of treatments, procedures and hospitalization per patient | — |
Countries
Spain
Outcome results
None listed